Excess revenues over expenses were $37.3 million for the year ended Sept. 30, compared to a $186.8 million deficit last year, according to the report.
Patient service revenues increased by $227.9 million (9.6%) in 2023. Discharges increased by 5.3%, which resulted in $166.1 million in additional patient service revenue.
Changes in payer mix and rate resulted in a net increase of $78.3 million (3%) while uncompensated care increased by $19.1 million (11.2%).
Other revenues increased by $53.3 million (20.3%) in 2023 compared to 2022, primarily due to Lifespan’s retail and contract pharmacies ($41.3 million) and favorable adjustments within value-based care models and shared savings ($10 million).
Total operating expenses increased by $224.2 million (7.8%) in 2023 due primarily to increases in compensation and benefits of $131.5 million (7.5%) and supplies and other expenses of $90.4 million (12.1%).
The system saw $28.7 million in non-operating gains in fiscal 2023, compared to non-operating losses of $130.8 million last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
